Analysis of the expression of hyaluronan in intraductal and invasive carcinomas of the breast

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 5, 2010, Pages 745-750

  Corte, Maria Daniela ^a   González, Luis Ovidio ^a,b   Junquera, Sara ^a   Bongera, Miguel ^a   Allende, Maria Teresa ^b,c   Vizoso, Francisco José ^a,b  

^a HOSPITAL DE JOVE   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Breast cancer; CD44; Hyaluronan; Tumoral invasion

Indexed keywords

ESTROGEN RECEPTOR; GLYCOSAMINOGLYCAN; HYALURONIC ACID; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER SIZE; CANCER STAGING; CELL MIGRATION; COMPUTER PROGRAM; CONTROLLED STUDY; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; BREAST TUMOR; CANCER INVASION; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DISEASE PROGRESSION; FEMALE; HUMANS; HYALURONIC ACID; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 77950504893     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0713-2     Document Type: Article

References (36)

1. Arai H, Kang KY, Sato H et al (1979) Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma. Am Rev Respir Dis 120:529-532
2. Auvinen P, Tammi R, Parkkinen J et al (2000) Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 156:529-536
3. Bertrand P, Girard N, Delpech B et al (1992) Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int J Cancer 52:1-6
4. Brown CT, Applebaum E, Banwatt R et al (1995) Synthesis of stromal glycosaminoglycans in response to injury. J Cell Biochem 59:57-68
5. Catterall JB, Jones LM, Turner GA (1999) Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clin Exp Metastasis 17:583-591
6. Consensus Conference (1997) Consensus conference on the classification of ductal carcinoma in situ. Hum Pathol 28:1221-1225.doi:10.1016/S0046-8177(97) 90193-90203
7. Corte MD, Gonzalez LO, Lamelas ML et al (2006) Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer. Breast Cancer Res Treat 97:329-337
8. de la Torre M, Wells AF, Bergh J et al (1993) Localization of hyaluronan in normal breast tissue, radial scar, and tubular breast carcinoma. Hum Pathol 24:1294-1297
9. Elston EW, Ellis IO (1993) Method for grading breast cancer. J Clin Pathol 46:189-190
10. Entwistle J, Hall CL, Turley EA (1996) HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem 61:569-577
11. Fraser JR, Laurent TC, Laurent UB (1997) Hyaluronan: its nature, distribution, functions and turnover. J Intern Med 242:27-33
12. Goebeler M, Kaufmann D, Brocker E et al (1996) Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. J Cell Sci 109(Pt 7):1957-1964
13. Hopwood JJ, Dorfman A (1978) Glycosaminoglycan synthesis by Wilms' tumor. Pediatr Res 12:52-56
14. Knudson W, Biswas C, Toole BP (1984) Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci USA 81:6767-6771 (Pubitemid 15221001)
15. Kosunen A, Ropponen K, Kellokoski J et al (2004) Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma. Oral Oncol 40:257-263
16. Koyama H, Hibi T, Isogai Z et al (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 170:1086-1099
17. Llaneza A, Vizoso F, Rodriguez JC et al (2000) Hyaluronic acid as prognostic marker in resectable colorectal cancer. Br J Surg 87:1690-1696
18. Ponting J, Howell A, Pye D et al (1992) Prognostic relevance of serum hyaluronan levels in patients with breast cancer. Int J Cancer 52:873-876
19. Prehm P (1984) Hyaluronate is synthesized at plasma membranes. Biochem J 220:597-600
20. Rooney P, Kumar S, Ponting J et al (1995) The role of hyaluronan in tumour neovascularization (review). Int J Cancer 60:632-636
21. Rudzki Z, Jothy S (1997) CD44 and the adhesion of neoplastic cells. Mol Pathol 50:57-71
22. Setala LP, Tammi MI, Tammi RH et al (1999) Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer 79:1133-1138
23. Sowa M, Kato Y, Nishimura M et al (1989) Clinico-histochemical studies on type 4 carcinoma of the stomach-with special reference to mucopolysaccharides and sialic acid in tumor tissue. Jpn J Surg 19:153-162
24. Sugahara KN, Murai T, Nishinakamura H et al (2003) Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 278:32259-32265
25. Suwiwat S, Ricciardelli C, Tammi R et al (2004) Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res 10:2491-2498
26. Takeuchi J, Sobue M, Sato E et al (1976) Variation in glycosaminoglycan components of breast tumors. Cancer Res 36:2133-2139
27. Toole BP (1990) Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol 2:839-844
28. Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528-539
29. Tzircotis G, Thorne RF, Isacke CM (2005) Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J Cell Sci 118:5119-5128
30. Udabage L, Brownlee GR, Nilsson SK et al (2005a) The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. Exp Cell Res 310:205-217
31. Udabage L, Brownlee GR, Waltham M et al (2005b) Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer. Cancer Res 65:6139-6150
32. UK National Coordinating Group for Breast Cancer Screening Pathology (1995) Pathology reporting in breast cancer screening, 2nd edn. NHSBSB Publications, Sheffield
33. Vizoso FJ, del Casar JM, Corte MD et al (2004) Significance of cytosolic hyaluronan levels in gastric cancer. Eur J Surg Oncol 30:318-324
34. Wang C, Tammi M, Guo H et al (1996) Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 148:1861-1869
35. Wernicke M, Pineiro LC, Caramutti D et al (2003) Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod Pathol 16:99-107
36. Zhang L, Underhill CB, Chen L (1995) Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res 55:428-433